Harminder Singh Sethi, MD is a healthcare provider in Hyattsville, MD specialising in hematology/oncology. Harminder is also listed as specialising in hematology & oncology.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Dr. Sethi is a hematology/oncology in Hyattsville, MD. This is the primary taxonomy recorded against the NPI in the federal registry, listed there as “HEMATOLOGY/ONCOLOGY”.
NPI registry
Dr. Sethi is listed at 6505 BELCREST RD SUITE #110, Hyattsville, MD 20782. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (301) 779-8800. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. Sethi's National Provider Identifier is 1275563033. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Sethi attended Other, graduating in 1990. This comes from the CMS National Downloadable File.
CMS public data
Dr. Sethi has 36 years experience. Calculated from a graduation year of 1990, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Sethi provides treatments such as injection of drug or substance under skin or into muscle and injection of additional new drug or substance into vein, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Sethi. If this is you, claiming it is free.
Guide.md
Source: NPPES NPI Registry
6505 BELCREST RD SUITE #110
Hyattsville, MD 20782
136,547 services · 3,695 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
896 |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
190 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
184 |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
148 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
70,980 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
18,360 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
12,180 |
| Injection, iron sucrose, 1 mg | Drug given | J1756 |
11,500 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
7,000 |
| Injection, ferric derisomaltose, 10 mg | Drug given | J1437 |
4,566 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Verify your identity to control how patients — and AI assistants — describe you.
Claim this profileConnections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other providers in the same specialty who trained at the same institution.
Providers who graduated from the same medical school in the same year.
Providers in MD who bill this service to Medicare most often.
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.